retatrutide weight loss trial retatrutide VisualAbstract: reduces body by 17.5% in patients with obesity Retatrutide Delivers Bariatric-Level Weight Loss
Description
These results are sustained long-term too, with 10.2% average weight loss maintained at four years when consistently using the medication
others stay on a maintenance dose
This is the first data in people showing that GLP-1s may affect DCIS survivorship, said poster presenter Danish Safi, MD , a medical oncologist at West Virginia University
Avoiding these mistakes can save you from having to replace the medication sooner than necessary
But 3.3% reported severe side effects
Injection site reactions Redness, swelling, or itching at the injection site
